WUXAY WuXi AppTec Co Ltd ADR Загрузка... : Бычьи и медвежьи мнения аналитиков
Загрузка графика...
Лучшие сигналы
Лента
22:19
04 авг
04 авг
Strong earnings and irreplaceable position in GLP-1.
WuXi AppTec reported a 20% earnings beat for Q2, driven by strong growth in its CMO and CDMO businesses. The company holds a 25% market share in the global GLP-1 (obesity) drug supply chain, and its US revenue portion has increased to 77% despite US sanctions, demonstrating its irreplaceable market position.
Выс.
05:01
04 авг
04 авг
WuXi AppTec booms on obesity drug demand
WuXi AppTec delivered a very strong earnings beat driven by surging obesity drug demand from both oral and injectable GLP-1. Raised capex guidance indicates robust future demand. Despite geopolitical noise and potential generic competition, pricing is already very affordable, and the company continues to deliver essential scale and quality that global pharma depends on.
Выс.
13:30
03 авг
03 авг
WuXi AppTec states that its placement on the Pentagon's Chinese military-linked list creates.
WuXi AppTec states that its placement on the Pentagon's Chinese military-linked list creates uncertainty for its critical US business operations.
Об аналитическом покрытии WUXAY
Buzzberg отслеживает WUXAY (WuXi AppTec Co Ltd ADR) в 3 источниках. Бычьих сигналов: 2, медвежьих: 0, от 3 аналитиков. Сентимент преимущественно бычий (67%). Всего отслеживаются 3 торговые идеи. За последние 7 дней: бычьих: 2, наблюдение: 1. Последние спикеры: Wang, Cui Cui, Bloomberg.